Spatial OMICS Market, By Technology (Spatial Transcriptomics, Spatial Genomics, Spatial Proteomics and Spatial Epigenomics), By Workflow, By Product, By Sample, By Application, By End User, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
|
Report ID
ANV6188
|
Published Date
October 2026
|
Pages
294
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Spatial OMICS market size was valued at US$ 320.8 Million in 2025, expanding at a CAGR of 9.9% from 2026 to 2033.
Spatial OMICS is a series of advanced techniques that can be used for the measurement and formation of spatial maps to quantify the presence of biological molecules such as RNA, protein, and metabolite in tissue sections, taking into account tissue architecture. In general, the Spatial OMICS technology consists of the combination of high-throughput sequencing and mass spectrometry technologies with imaging/microdissection technologies. Due to this technology, it becomes possible to correlate molecular data with the location in cells and tissues. This opens up the possibility of using ORIMS technology from the point of view of tissue architecture and thus creates an entirely new paradigm for understanding tumor heterogeneity and disease progression at a cellular, tissue, and positional level.
Spatial Omics Market- Market Dynamics
Advancements Of Precision Medicine To Propel Market Growth
The growing advancements in precision medicine are driving the adoption of spatial omics technologies. This is because detecting the locations of the genes, proteins, and other molecules increases the understanding of how diseases work, and it allows the identification of biomarkers that predict the patients\' response to the therapy and finding out their uniqueness. For example, according to the NIH Gov, in February 2026, advances in genomics play an important role in precision medicine by offering treatments that match patients\' genomes, environments, and lifestyles.
In particular, by July 9, 2025, the total number of phenotypes is 7634; the molecular mechanism for 799 phenotypes is known. This helps in screening and prevention of such diseases and helps in better treatment of such diseases. It is also found that 10% of respondents reject the concept of genetic testing, as they feel that it may be used against them, whereas 30% of the people refuse to go for genetic testing due to this reason. Therefore, these facts explain why the adoption of spatial omics technologies will be increasing in precision medicine and other healthcare fields.
Spatial Omics Market- Segmentation Analysis:
The Global Spatial Omics market is segmented on the basis of Technology, Workflow, Product, Sample, Application, End User, and Region.
Based on technology, the spatial transcriptomics segment holds a prominent share in the spatial biology market. This technology is being commonly used to understand the gene expression while keeping the spatial identity of the cells or tissues, thus being used in several applications like research on diseases, drug discovery, research of cancerous tumors, and tissue biology. In March 2026, 10x Genomics formed a strategic alliance with Bioptimus in order to develop the STELA spatial biology atlas that will make use of the Xenium spatial transcriptomics platform as the core technology in creating spatial datasets. These advancements are expected to enhance spatial transcriptomics adoption across research and clinical applications.
Spatial Omics Market- Geographical Insights
The North American region represents one of the important regions for the spatial OMICS market, as the region has a considerable number of investments made for its research and development activities. In March 2026, according to United for Medical Research (Org.), NIH provided a total amount of $36,580 million (USD) as research grants for organizations in 50 US states and the District of Columbia in the financial year 2025. The NIH research funding created 390,863 jobs and $94,150 million (USD) in economic activity in 2025. Each dollar invested in NIH research created 2.57 times the economic activity, i.e., the return on investment is 250%. The investment made by NIH in the past decade nationally has created $822,000 million (USD) of economic activity and 3.7 million jobs in the last decade nationally. These are expected to bolster research capabilities and growth potential of the Spatial Omics market in the region.
South Korea Spatial Omics Market - Country Insights
South Korea is currently growing rapidly because of the rise in the number of research centers focusing on innovation as well as the contribution of the government towards the development of biotechnology. For instance, as stated by Korea On Point Org, in July 2025, South Korea’s Bio Economy Initiative will place the nation among the top five bio-economies in the world by 2030. This will be made possible due to increased bio-manufacturing ecosystems, clinical trials of vaccine subsidies, and personalized medicines. In addition, the role of the government will continue in the development of biotechnology through various initiatives aimed at developing a bioeconomy in the country and helping grow the market in the forecasted period.
Spatial Omics Market- Competitive Landscape:
The Spatial Omics market comprises a number of existing as well as upcoming competitors, who are competing against each other in the development of new sequencing, imaging, multiplexing, and single-cell technologies so as to establish themselves in a better position in the market. Companies such as 10x Genomics, Illumina, NanoString, Akoya Biosciences, and Resolve Biosciences are just some of the prominent players that have gained significant recognition in the market through the use of integrated spatial analysis platforms and differentiating imaging technology. In June 2026, Illumina launched StrataMap Spatial Solution, which is an end-to-end sequencing-based spatial whole-transcriptome research solution that offers single-cell resolution, a larger capture area, and unbiased whole-transcriptome profiling in spatial biology research and discovery. Such developments can be beneficial for companies to conduct spatial biology research with greater resolution and whole-transcriptome profiling.
Recent Developments:
- In April 2025, Akoya Biosciences disclosed its collaboration with Enable Medicine to create the largest single-cell spatial proteomics atlas commercially available using over 100 million cells in 8,500+ samples and 15+ cancers in order to characterise the tumour microenvironment using Akoya’s PhenoCycler-Fusion technology.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL SPATIAL OMICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- 10x Genomics, Inc.
- Illumina, Inc.
- NanoString Technologies, Inc.
- Akoya Biosciences, Inc.
- Resolve Biosciences GmbH
- Bruker Corporation
- Bio-Techne Corporation
- Vizgen, Inc.
- RareCyte, Inc.
- Ionpath, Inc.
- Standard BioTools Inc.
- Rebus Biosystems, Inc.
- Lunaphore Technologies SA
- Dovetail Genomics (Cantata Bio)
- S2 Genomics, Inc.
- Ultivue, Inc.
- Others
GLOBAL SPATIAL OMICS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020 - 2033
- Spatial Transcriptomics
- Spatial Genomics
- Spatial Proteomics
- Spatial Epigenomics
GLOBAL SPATIAL OMICS MARKET, BY WORKFLOW- MARKET ANALYSIS, 2020 - 2033
- Sequencing-Based
- Imaging-Based
GLOBAL SPATIAL OMICS MARKET, BY PRODUCT- MARKET ANALYSIS, 2020 - 2033
- Instruments
- Consumables
- Software & Analytics
GLOBAL SPATIAL OMICS MARKET, BY SAMPLE- MARKET ANALYSIS, 2020 - 2033
- FFPE
- Fresh-Frozen
GLOBAL SPATIAL OMICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033
- Diagnostics
- Translational Research
- Drug Discovery & Development
- Cell Biology
- Others
GLOBAL SPATIAL OMICS MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033
- Academic & Translational Institutes
- CROs & CDMOs
- Pharmaceutical & Biotechnology Companies
- Others
GLOBAL SPATIAL OMICS MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Denmark
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Taiwan
- Vietnam
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Iran
- Qatar
- Rest of MEA
TABLE OF CONTENT
1. Spatial Omics Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.2. Competitive Insights
3. Spatial Omics Key Market Trends
3.1. Spatial Omics Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Spatial Omics Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Spatial Omics Market Opportunities
3.4. Spatial Omics Market Future Trends
4. Spatial Omics Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Spatial Omics Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Spatial Omics Market Landscape
6.1. Spatial Omics Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Spatial Omics Market – By Technology
7.1. Overview
7.1.1. Segment Share Analysis, By Technology, 2025 & 2033 (%)
7.1.2. Spatial Transcriptomics
7.1.3. Spatial Genomics
7.1.4. Spatial Proteomics
7.1.5. Spatial Epigenomics
8. Spatial Omics Market – By Workflow
8.1. Overview
8.1.1. Segment Share Analysis, By Workflow, 2025 & 2033 (%)
8.1.2. Sequencing-Based
8.1.3. Imaging-Based
9. Spatial Omics Market – By Product
9.1. Overview
9.1.1. Segment Share Analysis, By Product, 2025 & 2033 (%)
9.1.2. Instruments
9.1.3. Consumables
9.1.4. Software & Analytics
10. Spatial Omics Market – By Sample
10.1. Overview
10.1.1. Segment Share Analysis, By Sample, 2025 & 2033 (%)
10.1.2. FFPE
10.1.3. Fresh-Frozen
11. Spatial Omics Market – By Application
11.1. Overview
11.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
11.1.2. Diagnostics
11.1.3. Translational Research
11.1.4. Drug Discovery & Development
11.1.5. Cell Biology
11.1.6. Others
12. Spatial Omics Market – By End User
12.1. Overview
12.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
12.1.2. Academic & Translational Institutes
12.1.3. CROs & CDMOs
12.1.4. Pharmaceutical & Biotechnology Companies
12.1.5. Others
13. Spatial Omics Market – By Geography
13.1. Introduction
13.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
13.2. North America
13.2.1. Overview
13.2.2. Spatial Omics Key Manufacturers in North America
13.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
13.2.4. North America Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
13.2.5. North America Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
13.2.6. North America Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
13.2.7. North America Market Size and Forecast, By Sample, 2020 - 2033 (US$ Million)
13.2.8. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
13.2.9. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
13.2.10. U.S.
13.2.11. Canada
13.3. Europe
13.3.1. Overview
13.3.2. Spatial Omics Key Manufacturers in Europe
13.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
13.3.4. Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
13.3.5. Europe Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
13.3.6. Europe Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
13.3.7. Europe Market Size and Forecast, By Sample, 2020 - 2033 (US$ Million)
13.3.8. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
13.3.9. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
13.3.10. Germany
13.3.11. UK
13.3.12. France
13.3.13. Italy
13.3.14. Spain
13.3.15. The Netherlands
13.3.16. Sweden
13.3.17. Russia
13.3.18. Poland
13.3.19. Denmark
13.3.20. Rest of Europe
13.4. Asia Pacific (APAC)
13.4.1. Overview
13.4.2. Spatial Omics Key Manufacturers in Asia Pacific
13.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
13.4.4. APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
13.4.5. APAC Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
13.4.6. APAC Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
13.4.7. APAC Market Size and Forecast, By Sample, 2020 - 2033 (US$ Million)
13.4.8. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
13.4.9. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
13.4.10. China
13.4.11. India
13.4.12. Japan
13.4.13. South Korea
13.4.14. Australia
13.4.15. Indonesia
13.4.16. Thailand
13.4.17. Philippines
13.4.18. Taiwan
13.4.19. Vietnam
13.4.20. Rest of APAC
13.5. Latin America (LATAM)
13.5.1. Overview
13.5.2. Spatial Omics Key Manufacturers in Latin America
13.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
13.5.4. LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
13.5.5. LATAM Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
13.5.6. LATAM Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
13.5.7. LATAM Market Size and Forecast, By Sample, 2020 - 2033 (US$ Million)
13.5.8. LATAM Size and Forecast, By Application, 2020 - 2033 (US$ Million)
13.5.9. LATAM Size and Forecast, By End User, 2020 - 2033 (US$ Million)
13.5.10. Brazil
13.5.11. Mexico
13.5.12. Argentina
13.5.13. Colombia
13.5.14. Rest of LATAM
13.6. Middle East and Africa
13.6.1. Overview
13.6.2. Spatial Omics Key Manufacturers in Middle East and Africa
13.6.3. Middle East and Africa Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
13.6.4. Middle East and Africa Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
13.6.5. Middle East and Africa Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
13.6.6. Middle East and Africa Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
13.6.7. Middle East and Africa Market Size and Forecast, By Sample, 2020 - 2033 (US$ Million)
13.6.8. Middle East and Africa Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
13.6.9. Middle East and Africa Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
13.6.10. Saudi Arabia
13.6.11. UAE
13.6.12. Israel
13.6.13. Turkey
13.6.14. Algeria
13.6.15. Egypt
13.6.16. Iran
13.6.17. Qatar
13.6.18. Rest of MEA
14. Key Vendor Analysis- Spatial Omics Industry
14.1. Competitive Benchmarking
14.1.1. Competitive Dashboard
14.1.2. Competitive Positioning
14.2. Company Profiles
14.2.1. 10x Genomics, Inc.
14.2.2. Illumina, Inc.
14.2.3. NanoString Technologies, Inc.
14.2.4. Akoya Biosciences, Inc.
14.2.5. Resolve Biosciences GmbH
14.2.6. Bruker Corporation
14.2.7. Bio-Techne Corporation
14.2.8. Vizgen, Inc.
14.2.9. RareCyte, Inc.
14.2.10. Ionpath, Inc.
14.2.11. Standard BioTools Inc.
14.2.12. Rebus Biosystems, Inc.
14.2.13. Lunaphore Technologies SA
14.2.14. Dovetail Genomics (Cantata Bio)
14.2.15. S2 Genomics, Inc.
14.2.16. Ultivue, Inc.
14.2.17. Others
15. 360 Degree AnalystView
16. Appendix
16.1. Research Methodology
16.2. References
16.3. Abbreviations
16.4. Disclaimer
16.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL SPATIAL OMICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- 10x Genomics, Inc.
- Illumina, Inc.
- NanoString Technologies, Inc.
- Akoya Biosciences, Inc.
- Resolve Biosciences GmbH
- Bruker Corporation
- Bio-Techne Corporation
- Vizgen, Inc.
- RareCyte, Inc.
- Ionpath, Inc.
- Standard BioTools Inc.
- Rebus Biosystems, Inc.
- Lunaphore Technologies SA
- Dovetail Genomics (Cantata Bio)
- S2 Genomics, Inc.
- Ultivue, Inc.
- Others
GLOBAL SPATIAL OMICS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020 - 2033
- Spatial Transcriptomics
- Spatial Genomics
- Spatial Proteomics
- Spatial Epigenomics
GLOBAL SPATIAL OMICS MARKET, BY WORKFLOW- MARKET ANALYSIS, 2020 - 2033
- Sequencing-Based
- Imaging-Based
GLOBAL SPATIAL OMICS MARKET, BY PRODUCT- MARKET ANALYSIS, 2020 - 2033
- Instruments
- Consumables
- Software & Analytics
GLOBAL SPATIAL OMICS MARKET, BY SAMPLE- MARKET ANALYSIS, 2020 - 2033
- FFPE
- Fresh-Frozen
GLOBAL SPATIAL OMICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033
- Diagnostics
- Translational Research
- Drug Discovery & Development
- Cell Biology
- Others
GLOBAL SPATIAL OMICS MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033
- Academic & Translational Institutes
- CROs & CDMOs
- Pharmaceutical & Biotechnology Companies
- Others
GLOBAL SPATIAL OMICS MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Denmark
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Taiwan
- Vietnam
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Iran
- Qatar
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Analystview Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
